Viewer+

by Lumea  · Based in United States → — One Platform, Endless Possibilities
Pathology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

Lumea’s Viewer+ is an FDA-cleared digital pathology viewer designed as a diagnostic powerhouse for clinical settings. It integrates every diagnostic tool, including one-click molecular testing and access to an open AI marketplace, all on a single intuitive screen. This platform is built to optimize pathology workflows, delivering faster, more accurate diagnoses and enhancing efficiency. Viewer+ supports diagnostic and workflow-driven AI, offering lightning-fast slide rendering and customizable dashboards. It also features DxAlign technology for real-time comparison of multiple sections and stains of the same sample, ensuring images remain aligned with every adjustment.

The software provides comprehensive case management, allowing pathologists to manage slide orders, review gross images, access patient history, and track previous biopsy results in one place. It facilitates instant second opinions and collaboration within and outside networks. Viewer+ offers scalable storage options, including cloud-based or on-premise secure storage, and is designed for seamless integration with existing LIS systems.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • FDA-cleared for primary diagnosis in clinical settings
  • AI-driven workflows and open AI marketplace integration
  • Lightning-fast, full slide rendering
  • DxAlign for real-time comparison of multiple sections and stains
  • Customizable dashboards for personalized workflow
  • Comprehensive case management (slide orders, gross images, patient history)
  • Integrated diagnostic tools on a single screen
  • Instant second opinions and enhanced collaboration
  • Scalable cloud-based or on-premise secure storage options
  • Integration with existing LIS and EMR systems

Use Cases

  • Primary diagnosis in clinical pathology
  • Streamlining and optimizing pathology laboratory workflows
  • Improving diagnostic accuracy and quality in cancer detection
  • Facilitating remote consultations and expert collaboration
  • Advanced cancer diagnostics across various tissue types
  • Data management for research and quality assurance

What Physicians Need to Know

Evidence Base
Lumea Viewer+ is an FDA 510(k)-cleared diagnostic platform and has received CE marking under IVDR, ensuring adherence to regulatory standards for clinical use. It incorporates native AI and integrates third-party diagnostic AI algorithms from collaborators for enhanced efficiency and diagnostic capabilities. The platform is built on a foundation that addresses inconsistencies in tissue handling, which is crucial as pathology data informs nearly 70% of medical decisions.
Clinical Validation Studies
Viewer+ has received FDA 510(k) clearance for primary diagnosis in clinical settings, signifying its safety and effectiveness. It also holds CE marking under IVDR, validating its use in European clinical environments. Lumea highlights that numerous research studies demonstrate digital pathology's diagnostic accuracy is consistent with traditional methods. The platform supports AI-driven workflows that are designed to meet high standards of quality and cancer diagnostics.
Alert Fatigue Management
While Lumea Viewer+ emphasizes efficiency and streamlined workflows to enhance diagnostic accuracy and productivity, specific mechanisms for managing alert fatigue (e.g., alert categorization, thresholds, override data) are not explicitly detailed for this tool in the provided information.
Differential Diagnosis Support
Viewer+ offers robust support for differential diagnosis through its advanced viewing capabilities, including DxAlign technology, which allows dynamic, real-time comparison of multiple sections and stains of the same sample with images remaining aligned. It integrates diagnostic and workflow-driven AI, along with access to an open marketplace of third-party diagnostic AI algorithms, to augment diagnostic capabilities and help identify subtle patterns. The platform also facilitates 'Instant Second Opinions' by enabling pathologists to consult peers within and outside their network.
Clinical Workflow Integration
Viewer+ is designed as a 'diagnostic powerhouse' that integrates seamlessly with any existing Laboratory Information System (LIS) as a powerful plugin. It provides comprehensive case management, allowing pathologists to manage slide orders, review gross images, access patient history, and track previous biopsy results all within a single, intuitive system. The platform supports EMR integration for simplified report retrieval and information sharing and enables embedding molecular testing directly into the digital pathology workflow, including conditional ordering features for molecular tests.
Decision Audit Trail
Given Viewer+'s FDA 510(k) clearance and CE marking under IVDR for primary diagnosis, it is implicitly required to maintain secure, computer-generated, time-stamped electronic records that allow for the reconstruction of events related to data creation, modification, and deletion, in compliance with regulatory standards like FDA 21 CFR Part 11. While specific details of the audit trail functionality within Viewer+ are not explicitly provided, its regulatory clearances necessitate robust audit capabilities for accountability and data integrity.
Physician Tip

Leverage Viewer+'s DxAlign feature for real-time, side-by-side comparison of multiple tissue sections and stains to enhance diagnostic accuracy and efficiency. Utilize the integrated AI algorithms and the open marketplace for third-party AI tools to gain additional insights and support complex diagnoses. Take advantage of the 'Instant Second Opinions' feature for quick consultations with peers, fostering confident diagnoses. The comprehensive case management within a single screen helps streamline your workflow, allowing you to focus more on diagnosis and less on navigating disparate systems. Explore the conditional ordering feature for molecular tests to integrate advanced diagnostics seamlessly into your workflow.

Lumea Viewer+ is highly adaptable, designed to integrate seamlessly as a plugin with existing LIS systems (e.g., Zaya Pathology LIS, LigoLab) and EMRs, providing a unified digital pathology experience. It supports an open marketplace for integrating third-party diagnostic AI algorithms and facilitates the embedding of molecular testing directly into the digital pathology workflow, enhancing overall diagnostic capabilities and efficiency.

Details

Category Clinical Decision Support & Reference, Pathology AI
Pricing Contact for pricing — Custom quotes available upon request; no public tiers.
DeploymentCloud-based or on-premise
Compliance
BAA AvailableUnknown AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Yes AI-estimated

Viewer+ received FDA 510(k) clearance (K242244) for primary diagnosis in clinical settings. It is intended for viewing and management of digital images of scanned surgical pathology slides prepared from formalin-fixed paraffin embedded (FFPE) tissue, for use with the Hamamatsu NanoZoomer S360MD whole slide scanner and the Barco MDPC-8127 monitor.
Integrations
EHR Not specified
Specialties Pathology

What the Web Says

Viewer+ by Lumea is an FDA-cleared digital pathology software designed to enhance efficiency and diagnostic accuracy for pathologists. It aims to create a unified diagnostic ecosystem by integrating with Laboratory Information Systems (LIS) and AI-driven workflows, reducing physician burnout and accelerating diagnoses. The platform is particularly noted for its high-quality whole slide images and comprehensive case management features, allowing pathologists to manage various aspects of a case within a single interface.

Overall: Positive

Strengths

  • FDA-cleared for primary diagnosis, ensuring high standards of safety and effectiveness.
  • Enhances efficiency and diagnostic accuracy, with claims of signing out cases up to 50% faster.
  • Provides highest quality whole slide images, visually equivalent to traditional microscope views.
  • Offers comprehensive case management, integrating slide orders, patient history, and previous biopsy results in one place.
  • Features integrated tools, eliminating the need for multiple screens and manual test ordering.
  • Facilitates instant second opinions and subspecialty collaboration.

Limitations

  • Intended for use with specific hardware: Hamamatsu NanoZoomer S360MD whole slide scanner and Barco MDPC-8127 monitor.
  • Not intended for use with frozen sections, cytology, or non-FFPE hematopathology specimens.
  • Requires a learning curve for pathologists transitioning from traditional microscopy, which may temporarily dip throughput.
  • Successful implementation is dependent on good workflow design, adequate infrastructure, and sufficient change management.

Based on reviews from: The National Law Review, EIN Presswire, Lumea (lumeadigital.com), Apple Podcasts (Digital Pathology Today), Goldfinch Laboratory, accessdata.fda.gov

Last updated: 2026-07-25

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Viewer+

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Viewer+.

View all on YouTube

Frequently Asked Questions

Viewer+ is designed for seamless integration with most major EHR systems through standard APIs, allowing it to pull relevant patient data and push recommendations directly into your workflow. This minimizes disruption and ensures that decision support is available at the point of care without requiring you to switch between multiple applications.
Viewer+ leverages a comprehensive array of data sources, including patient demographics, medical history, lab results, imaging reports, and current medications from your EHR. It also incorporates up-to-date medical literature, clinical guidelines, and expert consensus to formulate its evidence-based recommendations.
Yes, Viewer+ is built with robust security measures and is fully compliant with HIPAA, GDPR, and other relevant data privacy regulations. It employs end-to-end encryption, access controls, and regular security audits to protect sensitive patient information and ensure confidentiality.
Viewer+ utilizes a rigorous process for curating its knowledge base, drawing from peer-reviewed journals, established clinical guidelines, and expert panels. The system undergoes continuous updates and validation by a team of medical professionals and data scientists to ensure its recommendations are current, accurate, and evidence-based.
While highly advanced, Viewer+ is a decision support tool and not a substitute for clinical judgment; it may not account for every unique patient variable or rare condition. Physicians should always critically evaluate its recommendations in the context of the individual patient's presentation, their own expertise, and institutional protocols.
Viewer+ distinguishes itself through its advanced AI-driven predictive analytics, comprehensive integration capabilities, and a highly customizable interface tailored to various specialties. Its continuous learning algorithms and commitment to transparent evidence sourcing often provide a more dynamic and adaptable support system compared to static rule-based alternatives.
Viewer+ offers flexible pricing models, including tiered subscriptions based on user count, features, and integration complexity. Options are available for individual practitioners, small clinics, and large hospital networks, with potential discounts for multi-year commitments or enterprise-level deployments.

Compare Viewer+

VS
Avenda Health AI Prostate Cancer Planning Software vs Viewer+
Clinical Decision Support & Reference Adjacent · 65/100
Avenda Health's Unfold AI is specifically designed for prostate cancer treatment planning, generating 3D maps from various patient data to aid in surgical and therapeutic decisions. Lumea's Viewer+…

Related Tools

DeepMind (Google)
Google DeepMind
Clinical Decision Support & Reference
AlphaFold is an AI system developed by DeepMind (Google) that accurately predicts protein structures and their interactions, significantly accelerating biological and medical research.
Free for non-commercial use
Tempus AI
Tempus AI
Clinical Decision Support & Reference
Tempus ECG-AI Platform uses artificial intelligence to analyze electrocardiogram data, offering advanced insights for cardiovascular diagnosis and management.
Cortex
Cortex
Clinical Decision Support & Reference
Cortex Workspace is a secure, HIPAA-compliant AI platform designed to streamline healthcare workflows and enhance decision-making for physicians.
Starts free, then $29/month for individual plan (save 10% annually). other plans: enthusiast ($99/month), business ($349/month), enterprise (contact sales).
SureMediks ProView
SureMediks (Rasimo Systems, LLC)
Clinical Decision Support & Reference
SureMediks is an AI-powered clinical decision support and metabolic health platform that automates care workflows for specialists, providing AI-generated patient summaries, automated chart review, and real-time biometric alerts.
SOAP Health
SOAP Health
Clinical Decision Support & Reference
SOAP Health is a Florida-based startup transforming patient intake with AI-powered diagnosis, offering a comprehensive solution that improves diagnosis accuracy and empowers patients and physicians.
Oxipit ChestLink
Oxipit (part of Sectra group)
Clinical Decision Support & Reference
Oxipit ChestLink is the world's first CE Class IIb-certified autonomous AI application for healthy chest X-ray reporting, capable of identifying normal studies with 99.9% sensitivity. It automates the reporting of normal chest X-rays, reducing radiologist workload and improving efficiency.

See all Clinical Decision Support & Reference tools →

More from Lumea

Lumea Digital Pathology
Lumea
Clinical Decision Support & Reference
Lumea is a specialty-specific digital pathology platform that covers the entire diagnostic workflow, from biopsy to final report, and integrates AI tools from partners like Paige and Mindpeak.
Lumea Viewer+
Lumea
Clinical Decision Support & Reference
Lumea Viewer+ is an FDA-cleared digital pathology viewer and diagnostic hub for pathologists, offering AI integration, lightning-fast image rendering, and comprehensive case management within a unified workflow.
Contact vendor

View company profile →

Suggest an Edit → | Last Verified: 2026-04-24 | First Added: 2026-04-24
AI Tool Finder
AI-powered search. Results may not be comprehensive.